A complex of EpCAM, claudin-7, CD44 variant isoforms, and tetraspanins promotes colorectal cancer progression
S Kuhn, M Koch, T Nubel, M Ladwein, D Antolovic… - Molecular Cancer …, 2007 - AACR
High expression of EpCAM and the tetraspanin CO-029 has been associated with colorectal
cancer progression. However, opposing results have been reported on CD44 variant …
cancer progression. However, opposing results have been reported on CD44 variant …
Deciphering cellular states of innate tumor drug responses
E Graudens, V Boulanger, C Mollard… - Genome biology, 2006 - Springer
Background The molecular mechanisms underlying innate tumor drug resistance, a major
obstacle to successful cancer therapy, remain poorly understood. In colorectal cancer …
obstacle to successful cancer therapy, remain poorly understood. In colorectal cancer …
Metastasis-associated factors facilitating the progression of colorectal cancer
YY Zhang, B Chen, YQ Ding - Asian Pacific journal of cancer …, 2012 - koreascience.kr
Tumor metastasis remains the principal cause of treatment failure and poor prognosis in
patients with colorectal cancer. It is a multistage process which includes proteolysis, motility …
patients with colorectal cancer. It is a multistage process which includes proteolysis, motility …
CD44v6 expression is related to mesenchymal phenotype and poor prognosis in patients with colorectal cancer
S Saito, H Okabe, M Watanabe… - Oncology …, 2013 - spandidos-publications.com
CD44 standard isoform (CD44s) is a cancer stem cell marker in many tumors, and is one of
the CD44 isoforms. CD44v6 has been reported to correlate with tumor progression and poor …
the CD44 isoforms. CD44v6 has been reported to correlate with tumor progression and poor …
Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer
Ezrin is a membrane-cytoskeleton anchor, which, in experimental models, regulates tumor
cell invasion and metastatic ability. We carried out immunohistochemical analysis of ezrin in …
cell invasion and metastatic ability. We carried out immunohistochemical analysis of ezrin in …
New Horizons in Metastatic Colorectal Cancer: Prognostic Role of CD44 Expression
Simple Summary In our study, we analyzed the role of CD44 expression as a prognostic
marker in patients with metastatic colorectal cancer. CD44 is a multi-structural and …
marker in patients with metastatic colorectal cancer. CD44 is a multi-structural and …
CD44: A New Prognostic Marker in Colorectal Cancer?
Simple Summary CD44 is a crucial factor in colorectal cancer, with specific isoforms
demonstrating their significance in the development, progression, metastasis, and …
demonstrating their significance in the development, progression, metastasis, and …
Low expression of chloride channel accessory 1 predicts a poor prognosis in colorectal cancer
B Yang, L Cao, J Liu, Y Xu, G Milne, W Chan… - Cancer, 2015 - Wiley Online Library
BACKGROUND Chloride channel accessory 1 (CLCA1) is a CLCA protein that plays a
functional role in regulating the differentiation and proliferation of colorectal cancer (CRC) …
functional role in regulating the differentiation and proliferation of colorectal cancer (CRC) …
[HTML][HTML] E-cadherin expression pattern in primary colorectal carcinomas and their metastases reflects disease outcome
A Elzagheid, A Ålgars, R Bendardaf… - World journal of …, 2006 - ncbi.nlm.nih.gov
AIM: To investigate the changes that occur in E-cadherin expression during the process of
metastasis in colorectal cancer. METHODS: E-cadherin expression was detected by …
metastasis in colorectal cancer. METHODS: E-cadherin expression was detected by …
[HTML][HTML] Nuclear β-catenin expression as a prognostic factor in advanced colorectal carcinoma
A Elzagheid, A Buhmeida, E Korkeila… - World journal of …, 2008 - ncbi.nlm.nih.gov
AIM: To investigate the changing pattern of β-catenin expression and its prognostic value in
advanced colorectal cancer (CRC). METHODS: Archival tumor samples were analyzed for β …
advanced colorectal cancer (CRC). METHODS: Archival tumor samples were analyzed for β …